FREE SHIPPING ON ORDERS OVER $150

kohjin glutathione study Efficacy of for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot Liposomal Opitac Glutathione in Celluglow™

$24.44

Quantity
- +
Description

[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., et al

kohjin glutathione study Efficacy of for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot Liposomal Opitac Glutathione in Celluglow

Keywords: Glutathione

kohjin glutathione study Efficacy of for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot Liposomal Opitac Glutathione in Celluglow

10.1016/j.freeradbiomed.2013.02.011 138 LiuL.KimS.BuckleyM

kohjin glutathione study Efficacy of for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot Liposomal Opitac Glutathione in Celluglow

Bibcode:2013JBiCh.28826480L

kohjin glutathione study Efficacy of for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot Liposomal Opitac Glutathione in Celluglow

You may also like

recommand products